(Q40365149)

English

In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7 x 10(10) colony-forming units

scientific article published on 24 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7 x 10(10) colony-forming units (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

0 references

placebo-controlled trial

1 reference

based on heuristic

inferred from title

typhoid vaccine

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Janet C. Lindow

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

C E Lyon

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

K S Sadigh

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

M P Carmolli

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

C Harro

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

C J Larsson

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

T Martinez

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

A Feller

9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

C H Ventrone

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

D A Sack

11

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

B DeNearing

12

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

A Fingar

13

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

K Pierce

14

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

E A Dill

15

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

H I Schwartz

16

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

E E Beardsworth

17

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

B Kilonzo

18

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

J P May

19

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

W Lam

20

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

A Upton

21

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

R Budhram

22

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

B D Kirkpatrick

23

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

24 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

3602-3608

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Putting typhoid vaccination on the global health agenda

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Salmonella typhi and S typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella Pathogenicity Island-2 (SPI-2) genes as vaccines and vectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Immunization of volunteers with Salmonella enterica serovar Typhi strain Ty21a elicits the oligoclonal expansion of CD8+ T cells with predominant Vbeta repertoires

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

Progress in vaccines against typhoid fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.02.017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40365149&oldid=1896225021"